LIST OF TABLES

TABLE 01.GLOBAL MS THERAPIES MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 02.IMMUNOSUPPRESSANTS MS THERAPIES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 03.IMMUNOMODULATORS MS THERAPIES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 04.GLOBAL MS THERAPIES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 05.MS THERAPIES MARKET FOR ORAL, BY REGION, 2018-2026 ($MILLION)
TABLE 06.INJECTABLE MS THERAPIES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 07.MS THERAPIES MARKET FOR INTRAVENOUS, BY REGION, 2018-2026 ($MILLION)
TABLE 08.MS THERAPIES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 09.NORTH AMERICA MS THERAPIES MARKET REVENUE, BY COUNTRY 2019-2026 ($MILLION)
TABLE 10.U.S. MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 11.U.S. MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 12.CANADA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 13.CANADA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 14.MEXICO MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 15.MEXICO MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 16.EUROPE MS THERAPIES MARKET REVENUE, BY COUNTRY 2018-2026 ($MILLION)
TABLE 17.UK MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 18.UK MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 19.GERMANY MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 20.GERMANY MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 21.FRANCE MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 22.FRANCE MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 23.ITALY MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 24.ITALY MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 25.SPAIN MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 26.SPAIN MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 27.REST OF EUROPE MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 28.REST OF EUROPE MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 29.ASIA-PACIFIC MS THERAPIES MARKET REVENUE, BY COUNTRY 2018-2026 ($MILLION)
TABLE 30.JAPAN MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 31.JAPAN MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 32.CHINA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 33.CHINA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 34.AUSTRALIA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 35.AUSTRALIA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 36.INDIA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 37.INDIA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 39.REST OF ASIA-PACIFIC MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 40.LAMEA MS THERAPIES MARKET REVENUE, BY COUNTRY 2018-2026 ($MILLION)
TABLE 41.BRAZIL MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 42.BRAZIL MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 43.SOUTH AFRICA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 44.SOUTH AFRICA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 45.SAUDI ARABIA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 46.SAUDI ARABIA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 47.REST OF LAMEA MS THERAPIES MARKET REVENUE, BY TYPE 2018-2026 ($MILLION)
TABLE 48.REST OF LAMEA MS THERAPIES MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION)
TABLE 49.ABBVIE: COMPANY SNAPSHOT
TABLE 50.ABBVIE: OPERATING BUSINESS SEGMENTS
TABLE 51.ABBVIE: PRODUCT PORTFOLIO
TABLE 52.BAYER.: COMPANY SNAPSHOT
TABLE 53.BAYER.: OPERATING SEGMENTS
TABLE 54.BAYER.: PRODUCT PORTFOLIO
TABLE 55.BIOGEN: COMPANY SNAPSHOT
TABLE 56.AMGEN: PRODUCT PORTFOLIO
TABLE 57.BMS: COMPANY SNAPSHOT
TABLE 58.BMS: OPERATING SEGMENTS
TABLE 59.BMS: PRODUCT PORTFOLIO
TABLE 60.ROCHE: COMPANY SNAPSHOT
TABLE 61.ROCHE: OPERATING SEGMENTS
TABLE 62.MERCK: COMPANY SNAPSHOT
TABLE 63.MERCK: OPERATING BUSINESS SEGMENTS
TABLE 64.MERCK: PRODUCT PORTFOLIO
TABLE 65.NOVARTIS: COMPANY SNAPSHOT
TABLE 66.NOVARTIS: OPERATING SEGMENTS
TABLE 67.NOVARTIS: PRODUCT PORTFOLIO
TABLE 68.PFIZER: COMPANY SNAPSHOT
TABLE 69.PFIZER: OPERATING SEGMENTS
TABLE 70.PFIZER: PRODUCT PORTFOLIO
TABLE 71.SANOFI: COMPANY SNAPSHOT
TABLE 72.SANOFI: OPERATING SEGMENTS
TABLE 73.SANOFI: PRODUCT PORTFOLIO
TABLE 74.TEVA: COMPANY SNAPSHOT
TABLE 75.TEVA: PRODUCT PORTFOLIO

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01.GLOBAL MS THERAPIES DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 05.TOP IMPACTING FACTORS
FIGURE 06.DRUGS IN DEVELOPMENT, 2019
FIGURE 07.COMPARATIVE ANALYSIS OF IMMUNOSUPPRESSANTS MS THERAPIES MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.COMPARATIVE ANALYSIS OF IMMUNOMODULATORS MS THERAPIES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.ORAL MS THERAPIES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.MS THERAPIES MARKET FOR INJECTABLE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.MS THERAPIES MARKET FOR INTRAVENOUS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.ABBVIE: NET SALES, 2016-2018 ($MILLION)
FIGURE 13.ABBVIE: REVENUE SALESBY SEGMENT,2018 (%)
FIGURE 14.ABBVIE: REVENUE SHARE BY REGION, 2018(%)
FIGURE 15.BAYER: NET SALES, 2016-2018 ($MILLION)
FIGURE 16.BAYER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 17.BAYER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 18.BIOGEN: NET SALES, 2016-2018 ($MILLION)
FIGURE 19.BMS: NET SALES, 2016-2018 ($MILLION)
FIGURE 20.BMS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 21.ROCHE: NET SALES, 2016-2018 ($MILLION)
FIGURE 22.ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 23.ROCHE: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 24.MERCK: NET SALES, 2016-2018 ($MILLION)
FIGURE 25.MERCK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 26.MERCK: REVENUE SHARE BY REGION, 2018(%)
FIGURE 27.NOVARTIS: NET SALES, 2016-2018 ($MILLION)
FIGURE 28.NOVARTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 29.NOVARTIS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 30.PFIZER: NET SALES, 2016-2018 ($MILLION)
FIGURE 31.PFIZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 32.PFIZER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 33.SANOFI: NET SALES, 2016-2018 ($MILLION)
FIGURE 34.SANOFI: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 35.SANOFI: REVENUE SHARE BY REGION, 2018(%)
FIGURE 36.TEVA: NET SALES, 2016-2018 ($MILLION)
FIGURE 37.TEVA: REVENUE SHARE BY REGION, 2018(%)